Multiple evidences have suggested that PP2A functions as a tumor suppressor [10], [11] by inhibiting several oncogenic kinases_ENREF_11 such as c-Myc and AKT [12]–[14], and tumor suppressors like p53 [15]. The gene discussed is PTPA; the disease is neoplasm.